Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Spinal Kinetics said it raised a $34 million funding round it plans to use to back a clinical trial for its M6-C cervical disc implant and inked a global settlement of its patent spat with Johnson & Johnson’s DePuy Synthes division.
The funding round was led by prior backers Scale Venture Partners, Lumira Capital, De Novo Ventures, SV Life Sciences and HLM Ventures, according to a press release. Read more
DexCom said it won pre-market approval from the FDA for its Dexcom G4 Platinum Professional continuous glucose monitor, touting it as the only professional-version CGM to offer real-time, unblinded feedback for patients and caregivers.
Patients use the G4 Platinum Professional CGM for 7 days as the device logs the rate and direction of glucose changes every 5 minutes. Read more
HeartWare International said today that the FDA issued a warning letter yesterday over procedures at a plant in Miami Lakes, Fla.
Framingham, Mass.-based HeartWare said the warning letter flagged 4 observations logged during an inspection of the Miami Lakes facility in January. Read more